CompletedPhase 3NCT01015547

Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Helsinki University Central Hospital
Principal Investigator
Pekka Lahdenne, MD, PhD
Hospital for Children and Adolescents in Helsinki University Central Hospital
Intervention
Infliximab plus methotrexate(drug)
Enrollment
60 enrolled
Eligibility
4-15 years · All sexes
Timeline
20032013

Study locations (6)

Collaborators

Foundation for Paediatric Research, Finland · Päivikki and Sakari Sohlberg Foundation, Finland · Rheumatism Foundation Hospital · Scandinavian Rheumatology Research Foundation · Paijat-Hame Hospital District

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01015547 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials